Searched for
CHOLESTEROL DRUG PRICING
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
- Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
- Novartis offers payment plan for high-cost heart medicineNovartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden ...
- Glenmark to pay $30 million in an antitrust settlement in US over cholesterol drug pricingThe company in an exchange notification said that it has entered into a three-year deferred prosecution agreement, and if the company adher...
- Drug pricing regulator NPPA fixes retail prices of 84 drug formulationsSimilarly, the price of Paracetamol and Caffeine has been fixed at Rs 2.88 per tablet. Besides, the price of one Rosuvastatin Aspirin and C...
- US charges Teva Pharmaceutical Industries Ltd in generic drugs price-fixing probeThe Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used p...
- Sun, Dr Reddy's among 7 Indian pharma majors sued in US for price riggingThe lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.
- NPPA fixes prices of 22 drug formulationsWhile National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations, it has also capped the ceiling prices of...
- Prices of 869 formulations to go up by 3.44%: NPPAThe development follows a price revision as per annual Wholesale Price Index (WPI) at the rate of 3.44 percent increase, the National Pharm...
- NPPA fixes retail prices of 14 formulationsDrug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.
- Ranbaxy launches Atorvastatin in 3 European countriesRanbaxy Laboratories today said it has launched generic versions of Atorvastatin tablets, used for treating cholesterol, in Italy, Sweden a...
- Watson Pharma launches Lipitor genericWatson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug.
- Ranbaxy gains over 5% in trade; drug release on trackShares of Ranbaxy climbed over 5 per cent in trade on Thursday on reports that the company will release a generic version Lipitor in the US...
- AstraZeneca India announces CRESTOR tablets launchAstraZeneca India announced the launch of CRESTOR® (rosuvastatin) 5, 10, 20 and 40 mg tablets. CRESTOR® is indicated for use in the treatme...
- Ranbaxy and Pfizer settle Lipitor patent disputesRanbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...
- Win some, lose someRanbaxy Laboratories’ third quarter net profit surged nearly seven times, but its share price declined after the results were announced.
- Pfizer Q3 profit doubles to $3.4bnPfizer on Thursday said third-quarter earnings doubled from the year-ago quarter when it took a big merger-related charge, helped by strong...
- Wal-Mart slashes prices of 300 generic drugs to $4Wal-Mart on Thursday said it would slash prices on nearly 300 generic prescription drugs to $4 starting in Tampa, Florida and plans to expa...
Load More
